ResMed Inc. (ASX:RMD)
Australia · Delayed Price · Currency is AUD 42.26
+0.79 (1.90%)
Sep 5, 2025, 4:10 PM AEST
ResMed Market Cap
ResMed has a market cap or net worth of 61.40 billion as of September 5, 2025. Its market cap has increased by 21.44% in one year.
Market Cap
61.40B
Enterprise Value
60.85B
Revenue
7.85B
Ranking
n/a
PE Ratio
28.74
Stock Price
42.26
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 53.86M to 61.40B, an increase of 113,900.59%. That is a compound annual growth rate of 26.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 61.40B | 13.15% |
| Dec 31, 2024 | 54.27B | 46.20% |
| Dec 29, 2023 | 37.12B | -17.49% |
| Dec 30, 2022 | 44.98B | -14.11% |
| Dec 31, 2021 | 52.37B | 31.17% |
| Dec 31, 2020 | 39.93B | 25.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 102.26B |
| Pro Medicus | 30.97B |
| Cochlear | 19.54B |
| Sonic Healthcare | 11.37B |
| Ramsay Health Care | 7.84B |
| Ansell | 4.99B |
| Telix Pharmaceuticals | 4.66B |
| Mesoblast | 2.55B |